3M Company
3M Company (MMM) Financial Performance & Income Statement Overview
Analyze 3M Company (MMM) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
3M Company (MMM) Income Statement & Financial Overview
Access detailed annual and quarterly income data for 3M Company MMM financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.95B | $6.01B | $6.29B | $6.25B |
| Cost of Revenue | $3.48B | $3.74B | $3.65B | $3.57B |
| Gross Profit | $2.48B | $2.27B | $2.65B | $2.68B |
| Gross Profit Ratio | $0.42 | $0.38 | $0.42 | $0.43 |
| R&D Expenses | $285.00M | $282.00M | $269.00M | $280.00M |
| SG&A Expenses | $945.00M | $899.00M | $1.06B | $1.13B |
| Operating Expenses | $1.23B | $1.18B | $1.33B | $1.41B |
| Total Costs & Expenses | $4.71B | $4.92B | $4.98B | $4.98B |
| Interest Income | $79.00M | $92.00M | $107.00M | $143.00M |
| Interest Expense | $255.00M | $252.00M | $276.00M | $322.00M |
| Depreciation & Amortization | $290.00M | $322.00M | $310.00M | $301.00M |
| EBITDA | $1.93B | $1.33B | $2.31B | $2.03B |
| EBITDA Ratio | $0.32 | $0.22 | $0.37 | $0.33 |
| Operating Income | $1.25B | $1.08B | $1.32B | $1.27B |
| Operating Income Ratio | $0.21 | $0.18 | $0.21 | $0.20 |
| Other Income/Expenses (Net) | $139.00M | -$326.00M | $405.00M | $138.00M |
| Income Before Tax | $1.39B | $759.00M | $1.72B | $1.41B |
| Income Before Tax Ratio | $0.23 | $0.13 | $0.27 | $0.23 |
| Income Tax Expense | $265.00M | $33.00M | $348.00M | $203.00M |
| Net Income | $1.12B | $728.00M | $1.37B | $1.15B |
| Net Income Ratio | $0.19 | $0.12 | $0.22 | $0.18 |
| EPS | $2.05 | $1.34 | $2.49 | $2.07 |
| Diluted EPS | $2.04 | $1.33 | $2.48 | $2.06 |
| Weighted Avg Shares Outstanding | $543.80M | $543.60M | $550.60M | $553.80M |
| Weighted Avg Shares Outstanding (Diluted) | $547.70M | $546.30M | $552.70M | $554.80M |
Financial performance has remained strong, with revenue growing from $6.25B in Q2 2024 to $5.95B in Q1 2025. Gross profit continued to perform well, with margins at 42% in the latest quarter. Operating income reached $1.25B in Q1 2025, holding a steady 21% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.93B. Net income rose to $1.12B, keeping EPS at $2.05. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan